Change Language

Select Language

Press Release:

Global Genomics Market to Grow at 15.54% During 2022-2027, Strengthened by Extensive Government Investments in Research

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global genomics market reached a value of US$ 25.11 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.26 Billion by 2027, exhibiting a CAGR of 15.54% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Genomics is the study of the function, mapping, structure, evolution, and genomes (genes) of an individual. It relies on consumables, systems, software, and services for diagnostics, drug discovery, development of precision medicine, and agricultural research. It aids in providing diagnostic and predictive insights that help healthcare professionals in research and finalizing treatment options for diseases, such as Alzheimer's, diabetes, and cancer. As a result, it is utilized around the world in studying biological systems and solving complex genetic problems in hospitals, private clinics, diagnostic, and research centers.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Significant advancements in the genomic field, increasing prevalence of chronic and infectious disorders among the masses, and rising preferences for personalized medicines are major factors bolstering the market growth. It can also be attributed to the growing adoption of non-invasive cancer screening-based research. In addition, the expanding global population, changing climatic conditions, rising food security concerns, and spreading awareness about the harmful effects of chemical-based fertilizers are driving the need for genomics to improve crop yield. This, in confluence with the shifting consumer preferences for organic food products, is contributing to the market growth. Furthermore, expanding investments in research and development (R&D) of biotechnology, coupled with extensive improvements in medical infrastructure and diagnostic technologies, are creating a positive outlook for the market. Apart from this, the integration of genomics-based apps and tests to identify DNA alterations is offering lucrative growth opportunities to industry investors.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genomics market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on component, application, technology, and end-user.

Breakup by Component:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Products
    • Instruments and Software
    • Consumables and Reagents
  • Services
    • Core Genomics Services
    • NGS-Based Services
    • Biomarker Translation Services
    • Computational Services
    • Others


Consumables and reagents hold the biggest market share as they aid in performing single-molecule and real-time (SMRT) sequencing.

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others


Functional genomics dominates the application segment as they help improve crop plants, human health, and livestock.

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others


Sequencing exhibits a clear dominance in the market as it provides information on genetic variants that can lead to different diseases.

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others


Pharmaceutical and biotechnology companies hold the majority of the total market share as they help modify genes and provide a new platform for the high-throughput genetic analysis of forest trees.

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


North America holds the majority of the global genomics market share on account of increasing preferences for personalized medicines.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are 23andMe, Inc, Agilent Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Component, Application, Technology, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Genomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Component 
    6.1    Products
        6.1.1 Market Trends
        6.1.2 Major Types
            6.1.2.1 Instruments and Software
            6.1.2.2 Consumables and Reagents
        6.1.3 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Major Types
            6.2.2.1 Core Genomics Services
            6.2.2.2 NGS-Based Services
            6.2.2.3 Biomarker Translation Services
            6.2.2.4 Computational Services
            6.2.2.5 Others
        6.2.3 Market Forecast
7   Market Breakup by Application
    7.1    Functional Genomics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Epigenomics
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Biomarkers Discovery
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Pathway Analysis
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Technology
    8.1    Sequencing
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Microarray
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Polymerase Chain Reaction
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Nucleic Acid Extraction and Purification
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market Breakup by End-User
    9.1    Research Centers
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospitals and Clinics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Pharmaceutical and Biotechnology Companies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Indicators
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    23andMe, Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
        15.3.2    Agilent Technologies, Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials 
           15.3.2.4 SWOT Analysis
        15.3.3    Bayer Aktiengesellschaft
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials 
           15.3.3.4 SWOT Analysis
        15.3.4    BGI Genomics Co. Ltd.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
        15.3.5    Bio-RAD Laboratories Inc.    
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials 
           15.3.5.4 SWOT Analysis
        15.3.6    Danaher Corporation
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials 
           15.3.6.4 SWOT Analysis
        15.3.7    Illumina Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    Oxford Nanopore Technologies
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials 
           15.3.8.4 SWOT Analysis
        15.3.9    PerkinElmer Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
        15.3.10    Myriad Genetics Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
        15.3.11    Roche Holding AG
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials 
        15.3.12    Thermo Fisher Scientific Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio 
           15.3.12.3 Financials 
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Genomics Market: Major Drivers and Challenges
Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Genomics Market: Breakup by Component (in %), 2021
Figure 4: Global: Genomics Market: Breakup by Application (in %), 2021
Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2021
Figure 7: Global: Genomics Market: Breakup by Region (in %), 2021
Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Genomics Industry: SWOT Analysis
Figure 90: Global: Genomics Industry: Value Chain Analysis
Figure 91: Global: Genomics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Genomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Genomics Market: Competitive Structure
Table 8: Global: Genomics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global genomics market was valued at US$ 25.11 Billion in 2021.

We expect the global genomics market to exhibit a CAGR of 15.54% during 2022-2027.

The extensive utilization of genomics for research activities and finalizing treatment options for
numerous diseases, such as Alzheimer's, diabetes, cancer, etc., is primarily driving the global
genomics market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of genomics to
study the impact of the coronavirus infection and develop vaccines, drugs, and testing kits for its
treatment.

Based on the component, the global genomics market has been divided into products and services,
where products, including consumables and reagents currently exhibit a clear dominance in the
market.

Based on the application, the global genomics market can be categorized into functional genomics,
epigenomics, biomarkers discovery, pathway analysis, and others. Currently, functional genomics
hold the majority of the total market share.

Based on the technology, the global genomics market has been segmented into sequencing,
microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. Among
these, sequencing represents the largest market share.

Based on the end-user, the global genomics market can be bifurcated into research centers,
hospitals and clinics, pharmaceutical and biotechnology companies, and others. Currently,
pharmaceutical and biotechnology companies account for the majority of the total market share.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global genomics market include 23andMe, Inc, Agilent
Technologies, Inc., Bayer AG, BGI Group, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina,
Inc., Oxford Nanopore Technologies, PerkinElmer, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche
Ltd, and Thermo Fisher Scientific Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Therapeutic Beds Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Medical Disposables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Contraceptive Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Cell-free Protein Expression Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links